Table of Contents - Espicom
Table of Contents - Espicom
Table of Contents - Espicom
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Diabetes Landscape: <strong>Table</strong> <strong>of</strong> <strong>Contents</strong><br />
5.17 Artificial Pancreas ..............................................................................................................................................................446<br />
Figure 5.170 – Artificial Pancreas – Top Assignees ....................................................................................................................................................................................446<br />
Priority Date by Year: ........................................................................................................................................................................... 447<br />
Figure 5.171 - Artificial Pancreas by Priority Date ......................................................................................................................................................................................447<br />
Priority Date by Year by Assignee: .................................................................................................................................................... 447<br />
Figure 5.172 - Artificial Pancreas by Priority Date by Assignee ..................................................................................................................................................................447<br />
Published Date by Year: ......................................................................................................................................................................448<br />
Figure 5.173 - Artificial Pancreas by Published Date ..................................................................................................................................................................................448<br />
IPC Analysis– Top 10 Codes: .............................................................................................................................................. 449<br />
Figure 5.174 - Artificial Pancreas by IPC Code .............................................................................................................................................................................................449<br />
USPC Analysis– Top 10 Codes: .......................................................................................................................................... 450<br />
Figure 5.175 - Artificial Pancreas by USPC Code ......................................................................................................................................................................................... 450<br />
Text Clustering Analysis: ..................................................................................................................................................................... 451<br />
Figure 5.176 – Artificial Pancreas - Text Clustering Analysis ...................................................................................................................................................................... 451<br />
Source Jurisdiction: .............................................................................................................................................................................. 452<br />
Figure 5.177 - Artificial Pancreas by Source Jurisdiction ............................................................................................................................................................................ 452<br />
Top Patents ............................................................................................................................................................................................ 453<br />
<strong>Table</strong> 5.17 - Top Patents Identified in the Artificial Pancreas Group........................................................................................................................................................... 453<br />
US6175752: Abbott Laboratories .................................................................................................................................... 454<br />
Figure 5.178 – Representative Image in US6175752 ..................................................................................................................................................................................454<br />
Figure 5.179 – Top 20 Companies Citing US6175752 ................................................................................................................................................................................. 455<br />
US6122536: Johnson & Johnson ...................................................................................................................................... 456<br />
Figure 5.180 – Representative Image in US6122536 ................................................................................................................................................................................. 456<br />
Figure 5.181 – Top 20 Companies Citing US6122536 ................................................................................................................................................................................. 457<br />
6.0 PATENT ANALYSIS BY KEY COMPANIES ............................................................................................... 458<br />
Figure 6.1 – Number <strong>of</strong> Patents versus Revenue for Highlighted Companies ........................................................................................................................................... 459<br />
Litigation ............................................................................................................................................................................ 460<br />
Figure 6.2 – Litigation Analysis .................................................................................................................................................................................................................460<br />
6.1 Johnson & Johnson .............................................................................................................................................................. 461<br />
Johnson & Johnson Overall Patent Portfolio ...................................................................................................................461<br />
Priority Date by Year: ........................................................................................................................................................................... 461<br />
Figure 6.3 – Johnson & Johnson Overall Patent Portfolio by Priority Year ................................................................................................................................................ 461<br />
Published Date by Year: ...................................................................................................................................................................... 462<br />
Figure 6.4 – Johnson & Johnson Overall Patent Portfolio by Published Year ............................................................................................................................................462<br />
Source Jurisdiction: .............................................................................................................................................................................. 462<br />
Figure 6.5 – Johnson & Johnson Overall Patent Portfolio Source Jurisdiction ...........................................................................................................................................462<br />
Johnson & Johnson Patents Specific to This Study ......................................................................................................... 463<br />
Figure 6.6 – Johnson & Johnson Diabetes Patents by Technology Group .................................................................................................................................................463<br />
Priority Date by Year: ...........................................................................................................................................................................464<br />
Figure 6.7 - Johnson & Johnson Diabetes Patents by Priority Year ............................................................................................................................................................464<br />
Publication Date by Year: .................................................................................................................................................. 464<br />
Figure 6.8 – Johnson & Johnson Diabetes Patents by Published Year.......................................................................................................................................................464<br />
IPC Analysis– Top 10 Codes: .............................................................................................................................................. 465<br />
Figure 6.9 – Johnson & Johnson Diabetes Patents by IPC Code .................................................................................................................................................................465<br />
USPC Analysis – Top 10 Codes: ...........................................................................................................................................................466<br />
Figure 6.10 – Johnson & Johnson Diabetes Patents by USPC Code ...........................................................................................................................................................466<br />
Source Jurisdiction: .............................................................................................................................................................................. 467<br />
Figure 6.11 – Johnson & Johnson Diabetes Patents by Source Jurisdiction ...............................................................................................................................................467<br />
6.2 Abbott Laboratories............................................................................................................................................................468<br />
Abbott Overall Patent Portfolio ....................................................................................................................................... 468<br />
Priority Date by Year: ...........................................................................................................................................................................468<br />
Figure 6.12 - Abbott Overall Patent Portfolio by Priority Year ....................................................................................................................................................................468<br />
Published Date by Year: ...................................................................................................................................................................... 469<br />
Figure 6.13 – Abbott Overall Patent Portfolio by Published Year ..............................................................................................................................................................469<br />
May 2012<br />
© <strong>Espicom</strong> Business Intelligence © 2012 UBM Semiconductor Insights<br />
xvii
Change language